
Work Here?
AMN Healthcare provides total talent solutions for healthcare organizations across the United States, connecting facilities with a large network of healthcare professionals. It manages the entire talent lifecycle with services such as managed services programs (MSP), vendor management systems (VMS), recruitment process outsourcing (RPO), executive search, temporary staffing, credentialing, language interpretation, and revenue cycle solutions. The platform uses data-driven insights to recruit, place, credential, and manage clinicians, aiming to reduce complexity, improve staffing efficiency, and support better patient care. It differentiates itself by offering end-to-end workforce management in one ecosystem, backed by a nationwide network and specialized back-office services that go beyond traditional staffing.
Industries
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1985
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
AMN Healthcare integrates AI interpreting amid pricing pressures. AMN Healthcare is strategically steering towards AI-enabled interpretation as financial pressures tighten around their traditional revenue streams. This move involves the recent acquisition of Jaide Health, a company whose technology facilitates routine healthcare communication, addressing vital interactions such as patient intake. Amidst a pricing downturn, AMN aims to leverage this technology to counterbalance declining rates in language services, a sector that's seen an 8% revenue drop in Q2 2026, compared to the previous year, as reported by Slator. The integration of AI solutions comes at a critical time when AMN's overall revenue from language services has shown only a marginal 1% recovery from Q1 2026 while witnessing a consistent compression in pricing. Specifically, interpreting service prices have diminished by 8% year-over-year and by 3% sequentially from Q1 2026. This trend signals a challenging market landscape where cost pressures and competition are prominent. It appears AMN is banking on AI-driven efficiencies to bolster performance and eventually enhance the gross margins of their language services by 2027. The financial narrative is coupled with AMN's broader economic landscape where the Technology and Workforce Solutions segment has also experienced a downturn. A 15% decline in revenue for this division in Q2 2026 reflects broader operational challenges, though AMN has demonstrated resilience by bouncing back from a significant USD 116.2 million loss in Q2 2025, realizing a USD 21.2 million net income in Q2 2026. The expected revenue for Q3 2026 remains between USD 640 million to 655 million, despite a forecasted 11% to 13% decline in the Technology and Workforce Solutions' revenue for the same period. These projections underscore the need for innovative strategies like the Jaide acquisition to sustain future growth. Ultimately, AMN Healthcare's pivot towards AI in medical interpreting represents a decisive response to a complex and evolving market. With competitive pricing eroding traditional revenue streams, adopting advanced technology not only aligns with industry trends but also positions the company for enhanced operational efficiency. As noted by Cary Grace, AMN's CEO and President, managing through client renewals and acquisitions will be crucial in navigating the headwinds described in Slator. Intelligence. Why this matters * AI integration aims to counteract revenue declines. * Acquisition of Jaide Health enhances healthcare communication. * Strategic pivot aligns with industry trends for efficiency. LSPs Enterprise Buyers Related reading. Keep independent coverage alive. No ads. No paywall. No corporate backing. Just sharp, weekly intelligence on the language industry - free, because it should be.
AMN Healthcare reported second quarter 2026 results that exceeded expectations, with consolidated revenue of $673 million, 6% above the high end of guidance and 2% higher year-over-year. Five of the company's solutions segments grew revenue compared to the prior year. Adjusted EBITDA reached $73 million, representing 10.9% of revenue and up 26% year-over-year. Adjusted earnings per share came in at $0.77, compared with $0.30 in the same quarter last year. The healthcare staffing company ended the quarter with $362 million in cash. Management indicated this provides capacity to invest in long-term strategy, including potential acquisitions. President and chief executive officer Caroline Grace said the quarterly performance came in better than the company had forecasted.
AMN Healthcare Services reported second-quarter results exceeding guidance, with revenue rising 2% year-over-year to $673 million. Adjusted EBITDA increased 26% to $73 million, whilst adjusted EPS reached $0.77, up from $0.30 in the prior-year quarter. Results benefited from $27 million in labour-disruption revenue and favourable reserve adjustments. The nurse and allied staffing segment showed significant strength, with revenue growing 11%. Travel nurse volume rose 6% and allied volume increased 7%, with travel nurse orders up approximately 40% year-over-year by early August. Performance varied across other businesses: search revenue grew 27%, but locums revenue fell 8% and technology and workforce solutions declined 15%. The company forecast third-quarter revenue of $640 million to $655 million, with adjusted EBITDA margins of 6.5% to 7%. AMN ended the quarter with $362 million in cash and equivalents.
AMN Healthcare Services reported second-quarter 2026 results that exceeded Wall Street expectations, with revenue of $673.2 million, up 2.3% year-on-year and beating analyst estimates of $628.2 million. The healthcare staffing company's non-GAAP earnings of $0.77 per share significantly surpassed the $0.19 consensus estimate. The company's third-quarter revenue guidance of $647.5 million at the midpoint came in 4.7% above analyst expectations. Adjusted EBITDA reached $73.36 million, beating estimates by 69.5%. Following the announcement, AMN Healthcare Services' stock jumped 11.5%. The company's operating margin improved to 4%, compared with negative 18.8% in the same quarter last year. Sales volumes increased 5.7% year-on-year. Free cash flow declined to negative $198.9 million from $68.75 million in the prior-year quarter.
AMN Healthcare Services director Mark G. Foletta has sold 3,681 shares indirectly for approximately $114,000 on 15 June 2026, according to an SEC Form 4 filing. The shares were sold at a weighted average price of $31.07. This marks Foletta's first open-market sale since 2023, with all transacted shares held via The Foletta Family Trust. Following the sale, he maintains an indirect position of 17,917 shares with no direct holdings or derivative securities. The transaction was executed under a Rule 10b5-1 trading plan adopted on 12 March 2026, indicating predetermined timing independent of market movements. The sale occurred during a strong year for AMN stock, which delivered a 40.9% gain. AMN Healthcare provides workforce solutions and staffing services to hospitals and health systems across the United States.
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
San Diego, California
Founded
1985
Find jobs on Simplify and start your career today